You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers

 

Online download statistics by month:

Online download statistics by month: July 2022 to February 2026

AbstractFullPdf
Jul 2022518531161
Aug 2022635663257
Sep 2022412431164
Oct 202224524898
Nov 202217117251
Dec 202214815057
Jan 202313313466
Feb 202311211963
Mar 2023848666
Apr 2023797955
May 2023505242
Jun 2023555640
Jul 2023535340
Aug 2023515137
Sep 2023444433
Oct 2023373934
Nov 2023646523
Dec 202316616626
Jan 2024585924
Feb 2024454522
Mar 20245556126
Apr 2024373733
May 2024424318
Jun 2024616029
Jul 2024606122
Aug 2024363723
Sep 20245862655
Oct 20246565287
Nov 2024565729
Dec 2024848666
Jan 2025606148
Feb 2025353537
Mar 2025515135
Apr 2025858571
May 2025595949
Jun 2025333333
Jul 2025110
Sep 2025110
Feb 2026110
Total404041342920